The trial will test the world's first mRNA-based personalised immunotherapy for melanoma.

Single cell analysis has been a revolutionary breakthrough in biology. Understanding cellular diversity has enabled significant insights into intracellular mechanisms and their applications to health and disease. But for many researchers, single cell has been out of reach due to technical, cost-per-cell, and scalability challenges.

Visium Spatial Gene Expression incorporates whole transcriptome analysis for intact tissues sections with morphological context. Bringing these complementary methods together offers a previously inaccessible view of tissue biology.

Enhancing human ex vivo translational outcomes.

This whitepaper by Sino Biological discusses the different types of stem cells based on their origin and potential, as well as the factors that direct their differentiation toward specific lineages or cell types.

Significant progress in iBio's in vivo preclinical programs with positive data from three antibody candidates: anti-EGFRvIII, CCR8, and TROP-2 x CD3.

Unveiling advancements in preclinical immuno-oncology: Exploring humanized mouse models and human knock-in mice for targeted cancer therapies.

The collaboration aims to expand access to immunotherapies and advance the field of CAR T cell therapy.

Single-Cell RNA-Sequencing CRO Service.

ChemPartner has the capabilities and expertise to support the end to end drug discovery process across multiple modalities (illustrated below with the small molecule flow scheme). We support the process with expertise and resources at every stage in a fully managed and integrated manner.

Overview of Capabilities.